Details
Stereochemistry | ACHIRAL |
Molecular Formula | 2Cl.Co.6H2O |
Molecular Weight | 237.931 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.O.O.O.O.O.[Cl-].[Cl-].[Co++]
InChI
InChIKey=GFHNAMRJFCEERV-UHFFFAOYSA-L
InChI=1S/2ClH.Co.6H2O/h2*1H;;6*1H2/q;;+2;;;;;;/p-2
DescriptionSources: https://pubchem.ncbi.nlm.nih.gov/compound/104729ISBN 9780873715980, Foden C.R., Weddell J.L., 'Hazardous Materials: Emergency Action Data' (1991), Retrieved from https://books.google.com/books?id=4IPE8Pjhm8UC&pgISBN: 978-94-010-7024-9, Matar M.S., Mirbach M.J.,Tayim H.A. 'Catalysis in Petrochemical Processes' (1988), p.136, Retrieved from https://books.google.com/books?id=MkD2JnDkZYYC&dqhttp://aygrt.isrj.org/colorArticles/4972.pdfhttp://onlinelibrary.wiley.com/doi/10.1002/3527600418.mb744048e0023/pdfhttps://www.ncbi.nlm.nih.gov/pubmed/27527840https://fscimage.fishersci.com/msds/05330.htmhttp://laboratorychemicals.in/uploads/msds/10026-17-2-49128.pdfhttps://www.ncbi.nlm.nih.gov/pubmed/2253206https://monographs.iarc.fr/ENG/Monographs/vol52/mono52-16.pdfhttp://datasheets.scbt.com/sc-227251.pdfCurator's Comment: description was created based on several sources, including:
DOI:10.1080/00958970802416020 | DOI:10.1080/00958972.2010.521553 | https://www.ncbi.nlm.nih.gov/pubmed/7201957 | https://www.ncbi.nlm.nih.gov/pubmed/18475879
Sources: https://pubchem.ncbi.nlm.nih.gov/compound/104729ISBN 9780873715980, Foden C.R., Weddell J.L., 'Hazardous Materials: Emergency Action Data' (1991), Retrieved from https://books.google.com/books?id=4IPE8Pjhm8UC&pgISBN: 978-94-010-7024-9, Matar M.S., Mirbach M.J.,Tayim H.A. 'Catalysis in Petrochemical Processes' (1988), p.136, Retrieved from https://books.google.com/books?id=MkD2JnDkZYYC&dqhttp://aygrt.isrj.org/colorArticles/4972.pdfhttp://onlinelibrary.wiley.com/doi/10.1002/3527600418.mb744048e0023/pdfhttps://www.ncbi.nlm.nih.gov/pubmed/27527840https://fscimage.fishersci.com/msds/05330.htmhttp://laboratorychemicals.in/uploads/msds/10026-17-2-49128.pdfhttps://www.ncbi.nlm.nih.gov/pubmed/2253206https://monographs.iarc.fr/ENG/Monographs/vol52/mono52-16.pdfhttp://datasheets.scbt.com/sc-227251.pdf
Curator's Comment: description was created based on several sources, including:
DOI:10.1080/00958970802416020 | DOI:10.1080/00958972.2010.521553 | https://www.ncbi.nlm.nih.gov/pubmed/7201957 | https://www.ncbi.nlm.nih.gov/pubmed/18475879
Cobaltous iodide is a catalyst used in organic synthesis.
Originator
Sources: http://www.rsc.org/periodic-table/element/27/cobalt
Curator's Comment: Cobalt was discovered by Georg Brandt, a Swedish chemist, in 1739.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Q9NWT6 Gene ID: 55662.0 Gene Symbol: HIF1AN Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/15941769 |
1.0 µM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Cobalt iontophoresis techniques for tracing afferent and efferent connections in the vertebrate CNS. | 1975 May 2 |
|
Inhalation toxicity studies of cobalt sulfate in F344/N rats and B6C3F1 mice. | 1990 Aug |
|
Effect of desferrioxamine and metals on the hydroxylases in the oxygen sensing pathway. | 2005 Aug |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/810127
For treatment of anemia, oral cobal chloride was administered at doses 25 mg and 50 mg daily.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15941769
HIF asparaginyl hydroxylase activity was measured by a method based on the hydroxylation coupled decarboxylation of 2-oxoglutarate with the synthetic HIF-1α peptides in the presence of varying concentrations of Co (1-5 uM). Ki for HIF asparaginyl hydroxylase was 1uM.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 189.120
Created by
admin on Fri Dec 15 16:56:09 GMT 2023 , Edited by admin on Fri Dec 15 16:56:09 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DBSALT002759
Created by
admin on Fri Dec 15 16:56:09 GMT 2023 , Edited by admin on Fri Dec 15 16:56:09 GMT 2023
|
PRIMARY | |||
|
DTXSID20999109
Created by
admin on Fri Dec 15 16:56:09 GMT 2023 , Edited by admin on Fri Dec 15 16:56:09 GMT 2023
|
PRIMARY | |||
|
100000128492
Created by
admin on Fri Dec 15 16:56:09 GMT 2023 , Edited by admin on Fri Dec 15 16:56:09 GMT 2023
|
PRIMARY | |||
|
24643
Created by
admin on Fri Dec 15 16:56:09 GMT 2023 , Edited by admin on Fri Dec 15 16:56:09 GMT 2023
|
PRIMARY | |||
|
17AVG63ZBC
Created by
admin on Fri Dec 15 16:56:09 GMT 2023 , Edited by admin on Fri Dec 15 16:56:09 GMT 2023
|
PRIMARY | |||
|
SUB35566
Created by
admin on Fri Dec 15 16:56:09 GMT 2023 , Edited by admin on Fri Dec 15 16:56:09 GMT 2023
|
PRIMARY | |||
|
17AVG63ZBC
Created by
admin on Fri Dec 15 16:56:09 GMT 2023 , Edited by admin on Fri Dec 15 16:56:09 GMT 2023
|
PRIMARY | |||
|
m3691
Created by
admin on Fri Dec 15 16:56:09 GMT 2023 , Edited by admin on Fri Dec 15 16:56:09 GMT 2023
|
PRIMARY | Merck Index | ||
|
7791-13-1
Created by
admin on Fri Dec 15 16:56:09 GMT 2023 , Edited by admin on Fri Dec 15 16:56:09 GMT 2023
|
PRIMARY | |||
|
1426883
Created by
admin on Fri Dec 15 16:56:09 GMT 2023 , Edited by admin on Fri Dec 15 16:56:09 GMT 2023
|
PRIMARY | RxNorm | ||
|
53503
Created by
admin on Fri Dec 15 16:56:09 GMT 2023 , Edited by admin on Fri Dec 15 16:56:09 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD